Trxade Group Divests Assets, Refocuses Pharmaceutical Strategy
Company Announcements

Trxade Group Divests Assets, Refocuses Pharmaceutical Strategy

Trxade Group (MEDS) has released an update.

TRxADE HEALTH Inc. has finalized a deal to sell the majority of its subsidiary Trxade, Inc.’s assets, which operates an online pharmaceutical trading platform, to Micro Merchant Systems, Inc. for $22.5 million, with potential adjustments. Following the sale, TRxADE HEALTH will continue its pharmaceutical wholesaling through Integra Pharma Solutions, LLC. The deal includes a possible additional payment of $7.5 million to Trxade, Inc. based on future earnings and standard indemnification clauses with a liability cap at 10% of the total purchase price. This strategic move is set to reshape TRxADE HEALTH’s business focus while ensuring a smooth transition of the online platform to MMS.

For further insights into MEDS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyTrxade Health announces name change to Scienture Holdings
TheFlyTrxade Health appoints Mani as President, Hariharan as CEO of Scienture
TipRanks Auto-Generated NewsdeskTrxade Group’s Strategic Merger and Rebranding as Scienture Holdings
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App